Cargando…
Optimized conditions for gene transduction into primary immune cells using viral vectors
Chimeric antigen receptor (CAR) T cell therapy has emerged as a promising modality for anti-cancer treatment. Its efficacy is quite remarkable in hematological tumors. Owing to their excellent clinical results, gene- modified cell therapies, including T cells, natural killer (NK) cells, and macropha...
Autores principales: | Kim, Yeongrin, Lee, Da Yeon, Choi, Ji U, Park, Jin Song, Lee, So Myoung, Kang, Chung Hyo, Park, Chi Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390464/ https://www.ncbi.nlm.nih.gov/pubmed/37524755 http://dx.doi.org/10.1038/s41598-023-39597-2 |
Ejemplares similares
-
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Kang, Chung Hyo, et al.
Publicado: (2021) -
Adeno-Associated Viral Vector 2 and 9 Transduction Is Enhanced in Streptozotocin-Induced Diabetic Mouse Retina
por: Lee, Si Hyung, et al.
Publicado: (2018) -
Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model
por: Lee, Si Hyung, et al.
Publicado: (2018) -
Retinal transduction profiles by high-capacity viral vectors
por: Puppo, Agostina, et al.
Publicado: (2014)